期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 76, 期 4, 页码 791-807出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-018-2978-6
关键词
NEU1; Elastin-derived peptides; Sialylation; CD36; Atherosclerosis
资金
- CNRS
- URCA
- Fondation de France
- Fraunhofer [Attract 069-608203]
- German Research Foundation (DFG) [HE 6190/1-2]
- LEO Foundation Center for Cutaneous Drug Delivery [2016-11-01]
- Region Champagne Ardenne
- NSFA (Nouvelle Societe Francophone d'Atherosclerose)
In addition to its critical role in lysosomes for catabolism of sialoglycoconjugates, NEU1 is expressed at the plasma membrane and regulates a myriad of receptors by desialylation, playing a key role in many pathophysiological processes. Here, we developed a proteomic approach dedicated to the purification and identification by LC-MS/MS of plasma membrane NEU1 interaction partners in human macrophages. Already known interaction partners were identified as well as several new candidates such as the class B scavenger receptor CD36. Interaction between NEU1 and CD36 was confirmed by complementary approaches. We showed that elastin-derived peptides (EDP) desialylate CD36 and that this effect was blocked by the V14 peptide, which blocks the interaction between bioactive EDP and the elastin receptor complex (ERC). Importantly, EDP also increased the uptake of oxidized LDL by macrophages that is blocked by both the V14 peptide and the sialidase inhibitor 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA). These results demonstrate, for the first time, that binding of EDP to the ERC indirectly modulates CD36 sialylation level and regulates oxidized LDL uptake through this sialidase. These effects could contribute to the previously reported proatherogenic role of EDP and add a new dimension in the regulation of biological processes through NEU1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据